Column Group GP, LP

This profile gathers the share dealings of Column Group GP, LP in NGM Biopharmaceuticals Inc. In total, 14 filings cover trades dated 5 April 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 8 April 2024 with a transaction in NGM Biopharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.